16 healthy men help unlock best way to take new cancer drug
NCT ID NCT06075277
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 28 times
Summary
This study tested whether taking the experimental drug Zongertinib with or without food changes how much of it gets into the blood. Sixteen healthy men each took one dose under both conditions. The results will help doctors decide the best way to give the drug in future trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Research Services Berlin GmbH
Berlin, 13627, Germany
Conditions
Explore the condition pages connected to this study.